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A B S T R A C T
The clear cell variant urothelial carcinoma of urinary bladder is very rare and unusual neoplasm defined histolo-
gically by clear cell pattern and glycogen–rich cytoplasm. Our case of clear cell carcinoma was diagnosed with immuno-
histochemistry stain. A 72-year-old man, presented with painless macroscopic hematuria in November 2007. Evaluation
revealed papillary tumor in urinary bladder. A transurethral resection of the bladder tumor (TUR-Bt) was performed.
Histopatologic evaluation showed superficial transitional cell carcinoma and carcinoma in situ. On three month fol-
low-up, a solitary pedunculated tumor was detected again in the left wall of the urinary bladder. A repeated trans-
urethral resection of the bladder tumor (reTUR-Bt) was performed in February 2008. The pathological diagnosis was
difficult due to diffuse clear cell appearance. Immunohistochemistry stain showed urothelial carcinoma and finally it
was diagnosed as clear cell variant. Urothelial carcinoma has many variants that show a variety of appearances and
characteristics. These should be well known for evaluation and optimal treatment.
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Introduction
The clear cell variant of urothelial carcinoma is de-
fined by clear cell pattern and glycogen-rich cytoplasm1.
This cells pattern may be either focal or extensive in tu-
mor component1.
The potential for divergent differentiation within uro-
tehilal cell carcinoma includes squamous, trophoblastic,
glandular, and small cell diferentiation, but today very
little is known about many urotehlial variant of carci-
noma. The WHO histological classification for urothelial
carcinoma has already described nine variants1. Their
apperence and progression is very characteristic and al-
most all variants predict for poor prognoses2. In our case,
we diagnosed clear cell variant superficial urothelial car-
cinoma of urinary bladder using immunohistochemicals
staining.
This is one of many variants of urothelial carcinoma
in the urinary bladder in the same patients.
Case Report
A 72-year-old man was admitted in emergency unit of
Dubrava University Hospital in November 2007 with
painless macroscopic hematuria. In evaluation, papillary
tumor was detected in urinary bladder. We performed
transurethral resection of the bladder tumor (TUR-Bt).
Histopatologic evaluation showed high grade superficial
transitional cell of urinary bladder and carcinoma in situ
(Figure 1). On follow-up, a papillary pedunculated tumor
was detected after three months in the left wall of the
urinary bladder. A recurrence transurethral resection of
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the bladder tumor (reTUR-Bt) was performed in Febru-
ary 2008. The pathological diagnosis was difficult due to
diffuse clear cell appearance. Immunohistochemistry stain
showed urothelial carcinoma.
Computerized tomography (CT) of abdomen and pel-
vis did not showed progression or metastasis of tumor.
Macroscopic features showed the tumor in size 1cm,
described as solitary pedunculated mass involving left
wall of the bladder.
Microscopic examination of the specimen showed su-
perficial non invasive, diffuse clear cytoplasm with se-
vere nuclear atypia and alveolar growth pattern (Figure
2). Compared to the first patohistological analysis that
showed high grade papillary tumor, now we found tumor
cells with clear cytoplasm. At first biopsy, when we per-
formed immunohistochemical staining, a results was
specific for urothelial carcinoma (cytokeratin 7, cytoke-
ratin 20, cytokeratin 34betaE12, vimentin and carcino-
embrionic antigen /CEA/). Immunohistochemical stain-
ing at second biopsy showed strongly positive stain with
percentage tumor positive cells of all tumor cells for
CK20, CEA and vimentin.
This immunohistochemical finding defines clear cell
carcinoma, so we finally diagnosed the tumor as clear cell
variant of urothelial carcinoma in the urinary bladder.
After 6 months of follow-up the patient had no recur-
rence of tumor in the urinary bladder.
Discussion
Many different tumors show a clear cell appearance,
and may originate from the kidney, bladder, prostate or
female genital tract especially from uterus and ovary4–7.
It is sometimes difficult to diagnose the primary site
of tumor growth due to morphological similarity between
tumors3–7.
In this case the differential diagnosis may include
metastasic tumors to the bladder of the renal cell carci-
noma, clear cell adenocarcinoma and clear cell variant of
urothelial carcinoma.
Renal clear cell carcinoma (CCC) may rarely meta-
stasize to the urinary bladder and approximately 30
cases have been reported in the literature7. Most fre-
quently, renal CCC is represented by a compact alveolar
growth of tumor cells, hobnail cells are not a feature.
Specific for renal CCC is the presence of very delicate
blood vessels surrounding the nests of tumor cells.
Clear cell adenocarcinoma has unique morphology,
showing one or more of typical three morphological pat-
terns: tubulocystic, papillary, and diffuse2. Hobnail cells
are frequently seen, but in our case we saw neither hob-
nail cells nor the characteristic histological patterns, and
we ruled out clear cell adenocarcinoma of urinary blad-
der.
In our case, it was difficult to diagnose using only the
hematoxilin and eosin stain, so we used immunohisto-
logical staining to assist in the diagnosis.
Urothelial carcinomas exhibit many variants and so-
me differentiation1,3. Severe progression is usually pre-
dicted when variants are found. Each variant shows a
characteristic appearance and specific pattern of prog-
ress. For example, micropapillary variants tend to show
vascular and lymphatic invasion, with a high incidence of
metastasis.
Nested variants closely resemble Brunn nests in their
infiltration of lamina propria and deceptively benign ap-
pearance; however, the prognosis is extremely poor. Awa-
reness of the clear cell variant is critical in making cor-
rect differential diagnoses1,2. This cells variant of uro-
thelial carcinoma is defined by a clear cell pattern and a
glycogen-rich cytoplasm. Clear cell patern may be either
focal or extensive in the tumor component1.
Nine cases have been reported previously but clinical
information was available for only four cases6,8,9. The
male to female ratio was 1:1, mean age was 67.2 years2.
Two patients presented with macroscopic hematuria,
and the others presented with bladder irritation. All
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Fig. 1. Urothelial carcinoma of urinary bladder (HEx100).
Fig. 2. Clear cell variant urothelial carcinoma of urinary blad-
der (HEx100).
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showed invasive carcinoma and open radical surgery was
chosen for all cases. In our cases the tumor is superficial
with no invasion of muscular layers.
According to patient age and histological analysis, we
decided to observe and prevent progression of disease
(cystoscopic examination, urine cytological analysis).
In conclusion, we pointed out different variation of
same histological urinary bladder carcinoma. Variability
as well as unpredictable malignant transformation has
important role in evaluation and decision for adequate
treatment.
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UROTELNI KARCINOM SVJETLIH STANICA MOKRA]NOG MJEHURA; KLINI^KO-PATOLO[KA
I IMUNOHISTOKEMIJSKA ANALIZA – PRIKAZ SLU^AJA
S A @ E T A K
Oblik urotelnog karcinoma mokra}nog mjehura svijetlih stanica vrlo je rijetka i neobi~na neoplazma definirana
histolo{ki svijetlim stanicama s citoplazmom bogatom glikogenom. Na{ slu~aj karcinoma svijetlih stanica dijagnostici-
ran je imunohistokemijski. Mu{karac, u dobi od 72 godine, klini~ki prezentiran s bezbolnom makroskopskom hematu-
rijom u studenom 2007. godine. Evaluacijom mokra}nog mjehura na|ena je papilarna tvorba. U~injena je transuretral-
na resekcija tumora mokra}nog mjehura (TUR). Histopatolo{ka evaluacija pokazala je da se radi povr{nom karcinomu
prijelaznog epitela i karcinomu in situ. Nakon 3 mjeseca pra}enja, ponovno je otkriven solitarni pedunkularni tumor s
lijeve lateralne strane mokra}nog mjehura. Ponovna transuretralna resekcija tumora mokra}nog mjehura (reTUR)
u~injena je u velja~i 2008. godine. Patolo{ka dijagnoza je bila ote`ana zbog difuznog prisustva svijetlih stanica. Imuno-
histokemijska analiza je dokazala urotelni karcinom, te je postavljena kona~na dijagnoza kao oblik urotelnog karci-
noma svijetlih stanica. Urotelni karcinom ima mnogo varijanti koje pokazuju razli~ite oblike i karakteristike. To bi
trebalo uzeti u obzir kod evaluacije i izbora optimalnog lije~enja.
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